| Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056 (NCT00700986) | AstraZeneca | 2008-06-01 |
| Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (NCT00674362) | UCB Pharma | 2008-06-01 |
| Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) (NCT00147966) | University of California, San Diego | 2008-06-01 |
| Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis (NCT01076959) | Abbott | 2008-06-01 |
| Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA) (NCT00786227) | Stanford University | 2008-06-01 |
| Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose) (NCT00794118) | Pfizer | 2008-06-01 |
| Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects (NCT02151409) | Novo Nordisk A/S | 2008-06-01 |
| LPS Flex Porous Femoral Components (NCT01462240) | Zimmer Biomet | 2008-05-20 |
| Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis (NCT00695188) | Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation | 2008-05-01 |
| Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) (NCT00665626) | Rigel Pharmaceuticals | 2008-05-01 |
| Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis (NCT00667758) | Betanien Hospital | 2008-05-01 |
| A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA) (NCT00771251) | Janssen Pharmaceutical K.K. | 2008-05-01 |
| Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (NCT00721994) | Corin | 2008-05-01 |
| Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (NCT00665925) | Rigel Pharmaceuticals | 2008-05-01 |
| A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00727987) | Janssen Pharmaceutical K.K. | 2008-05-01 |
| A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate (NCT01224418) | Astellas Pharma Inc | 2008-05-01 |
| Cormet Post-PMA Study: New Enrollment (NCT00722007) | Corin | 2008-04-24 |
| A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy (NCT00673920) | Genentech, Inc. | 2008-04-24 |
| A Study on Rheumatoid Arthritis Patients Treated With Rituximab (NCT02622503) | Hoffmann-La Roche | 2008-04-01 |
| Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment (NCT00902005) | Revmatismesykehuset AS | 2008-04-01 |
| A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) (NCT00661284) | Chugai Pharmaceutical | 2008-04-01 |
| Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use (NCT01083160) | Abbott | 2008-04-01 |
| Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan (NCT00661661) | Pfizer | 2008-04-01 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis (NCT00641225) | Pfizer | 2008-03-31 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate (NCT01000610) | Hoffmann-La Roche | 2008-03-17 |
| Long Term Experience With Abatacept in Routine Clinical Practice (NCT02109666) | Bristol-Myers Squibb | 2008-03-01 |
| Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III) (NCT00664521) | Merck KGaA, Darmstadt, Germany | 2008-03-01 |
| A Study of ARRY-438162 in Patients With Rheumatoid Arthritis (NCT00650767) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Effects of Probiotics on Rheumatoid Arthritis Patients (NCT00664820) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-03-01 |
| Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis (NCT00650078) | Amgen | 2008-03-01 |
| Fitmore Hip Stem PMCF Study: A Multi-centre, Non-comparative, Prospective Post-market Clinical Follow-up Study. (NCT03411044) | Zimmer Biomet | 2008-02-08 |
| Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) (NCT01017367) | Bristol-Myers Squibb | 2008-02-01 |
| Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients (NCT00556894) | Can-Fite BioPharma | 2008-02-01 |
| Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00639834) | Bristol-Myers Squibb | 2008-02-01 |
| 3DKnee™ System vs. the MJS Knee System (NCT00764803) | Encore Medical, L.P. | 2008-01-01 |
| Effect of Healing on Rheumatoid Arthritis (NCT00967395) | Henning Bliddal | 2008-01-01 |
| A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) (NCT00741104) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study (NCT00793403) | Pfizer | 2008-01-01 |
| Efficacy of the CLP® Hip - Retrospective (NCT00764842) | Encore Medical, L.P. | 2008-01-01 |
| Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care (NCT01163916) | Abbott | 2008-01-01 |
| A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA) (NCT01362153) | Centocor, Inc. | 2007-12-26 |
| Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response (NCT03414502) | University of Nebraska | 2007-12-10 |
| PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity (NCT00576706) | Korea Otsuka Pharmaceutical Co., Ltd. | 2007-12-01 |
| Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis (NCT00963703) | University of Manitoba | 2007-12-01 |
| A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis (NCT01231321) | Abbott | 2007-12-01 |
| A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector (NCT00643526) | Centocor, Inc. | 2007-12-01 |
| Dosing Flexibility Study in Patients With Rheumatoid Arthritis (NCT00580840) | UCB Pharma | 2007-12-01 |
| A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. (NCT00580229) | University of South Florida | 2007-12-01 |
| Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing (NCT00647270) | Abbott | 2007-12-01 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. (NCT00576433) | Hoffmann-La Roche | 2007-12-01 |
| Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis (NCT00302952) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-11-06 |
| Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis (NCT00840957) | University Hospital, Tours | 2007-11-01 |
| Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA) (NCT01078116) | Abbott | 2007-11-01 |
| 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants (NCT00664573) | Biogen | 2007-11-01 |
| Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA) (NCT00839020) | Aesculap AG | 2007-11-01 |
| Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder (NCT00737087) | DePuy International | 2007-11-01 |
| PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease (NCT00554853) | University of Michigan | 2007-11-01 |
| A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate (NCT00578305) | Hoffmann-La Roche | 2007-11-01 |
| Phase IIIB Subcutaneous Missed Dose Study (NCT00533897) | Bristol-Myers Squibb | 2007-11-01 |
| Ankle Joint Replacement Outcomes Study (NCT00503438) | Smith & Nephew, Inc. | 2007-10-31 |
| A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis (NCT00535782) | Hoffmann-La Roche | 2007-10-31 |
| A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. (NCT00502853) | Hoffmann-La Roche | 2007-10-25 |
| Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis (NCT00554606) | Novartis | 2007-10-11 |
| Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis (NCT00551707) | Zalicus | 2007-10-01 |
| Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer (NCT00595517) | AstraZeneca | 2007-10-01 |
| Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis (NCT00796809) | University of Arizona | 2007-10-01 |
| Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis (NCT00626275) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2007-10-01 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate (NCT00934648) | Hoffmann-La Roche | 2007-10-01 |
| A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis (NCT00550043) | Incyte Corporation | 2007-10-01 |
| Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis (NCT02699892) | Hoffmann-La Roche | 2007-10-01 |
| Retrospective Study of the Linear™ Hip (NCT00764959) | Encore Medical, L.P. | 2007-10-01 |
| A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis (NCT00531817) | Hoffmann-La Roche | 2007-10-01 |
| Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate (NCT00525213) | OxyPharma | 2007-10-01 |
| Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis (NCT00545454) | Sanofi | 2007-10-01 |
| Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II) (NCT00595413) | EMD Serono | 2007-09-01 |
| Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design (NCT01102829) | Leiden University Medical Center | 2007-09-01 |
| Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis (NCT00411424) | Astellas Pharma Inc | 2007-09-01 |
| Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (NCT00459706) | Pfizer | 2007-09-01 |
| Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) (NCT00613106) | Amgen | 2007-09-01 |
| Remission Induction in Very Early Rheumatoid Arthritis (NCT00523692) | University Hospital Birmingham | 2007-09-01 |
| Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury (NCT00597818) | Sucampo Pharma Americas, LLC | 2007-08-01 |
| Duke Autoimmunity in Pregnancy Registry (NCT00513591) | Duke University | 2007-08-01 |
| A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) (NCT00520572) | AstraZeneca | 2007-08-01 |
| CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study (NCT00522002) | George Washington University | 2007-08-01 |
| Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate (NCT00538902) | Abbott | 2007-08-01 |
| A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems (NCT00699270) | Biomet Orthopedics, LLC | 2007-08-01 |
| BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861) (NCT00523328) | Biogen | 2007-08-01 |
| A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability (NCT00517543) | GlaxoSmithKline | 2007-08-01 |
| Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis (NCT00505089) | Novartis | 2007-08-01 |
| Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID (NCT00542789) | AstraZeneca | 2007-08-01 |
| A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. (NCT00502840) | Hoffmann-La Roche | 2007-07-23 |
| Exactech Shoulder Post Market Clinical Follow-up Study (NCT05603728) | Exactech | 2007-07-19 |
| A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents. (NCT00504777) | Hoffmann-La Roche | 2007-07-01 |
| Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan (NCT00503139) | Pfizer | 2007-07-01 |
| Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants (NCT00664716) | Biogen | 2007-07-01 |
| The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis (NCT00372177) | Biotectid GmbH | 2007-07-01 |
| Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy (NCT00405275) | US Department of Veterans Affairs | 2007-07-01 |
| Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis (NCT00555230) | Chinese University of Hong Kong | 2007-07-01 |
| A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) (NCT00485589) | Genentech, Inc. | 2007-06-11 |
| A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies. (NCT00462345) | Hoffmann-La Roche | 2007-06-01 |